The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR)
Open accessAbstract
Insulin resistance and insulin hypersecretion are established features of obesity. Their prevalence, however, has only been inferred from plasma insulin concentrations. We measured insulin sensitivity (as the whole-body insulin-mediated glucose uptake) and fasting posthepatic insulin delivery rate (IDR) with the use of the euglycemic insulin clamp technique in a large group of obese subjects in the database of the European Group for the Study of Insulin Resistance (1,146 nondiabetic, normotensive Caucasian men and women aged 18-85 yr, with a body mass index (BMI) ranging from 15 to 55 kg.m-2). Insulin resistance, defined as the lowest decile of insulin sensitivity in the lean subgroup (608 subjects with a mean BMI of 29 kg.m-2). Insulin sensitivity declined linearly with BMI at an age- and sex-adjusted rate of 1.2 micromol.min-1.kg FFM-1 per BMI unit (95% confidence intervals = 1.0-1.4). Insulin hypersecretion, defined as the upper decile of IDR, was significantly (P<0.0001) more prevalent (38%) than insulin resistance in the obese group. In the whole dataset, IDR rose as a function of both BMI and insulin resistance in a nonlinear fashion. Neither the waist circumference nor the waist-to-hip ratio, indices of body fat distribution, was related to insulin sensitivity after adjustment for age, gender, and BMI; both, however, were positively associated (P<0.001) with insulin hypersecretion, particularly in women. In nondiabetic, normotensive obese subjects, the prevalence of insulin resistance is relatively low, and is exceeded by the prevalence of insulin hypersecretion, particularly in women with central obesity. In the obese with preserved insulin sensitivity, risk for diabetes, cardiovascular risk, and response to treatment may be different than in insulin resistant obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because the great majority of glucose disposal after intravenous glucose administration occurs in muscle, these results provide strong evidence that insulin resistance in muscle is the earliest demonstrable defect in the natural history of type 2 diabetes, but that the development of overt type 2 diabetes occurs only in those individuals whose β-cells are unable to compensate for the defect in”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [48]
Experimental — accuracy not yet measuredIn the citing paper
“Given the strong association between BMI and insulin sensitivity (8), groups with large differences in insulin sensitivity are generally difficult to match for BMI and fat mass, complicating data interpretation.”
From Metabolic flexibility to lipid availability during exercise is enhanced in individuals with high insulin sensitivity (2018) · cites this paper as [8]
In the citing paper
“A similar relationship also exists between BMI and the degree of insulin resistance.22”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [22]
In the citing paper
“one study reported that 19, 34 and 60% of individuals with a BMI of <30, ≥30–35 and >35, respectively, were insulin resistant.22”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [22]
In the citing paper
“It is well established that there is a generally directly proportional relationship between BMI and both fasting and postprandial insulin levels.21,22”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [22]
In the citing paper
“The hyperinsulinemia associated with rising BMI is necessary to overcome insulin resistance and maintain normoglycemia.22”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [22]
In the citing paper
“Insulin hypersecretion also becomes more frequent with increasing BMI;24 28, 49 and 80% of individuals with a BMI of <30, >30–35 and >35, respectively, exhibited insulin hypersecretion.22”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Increasing Prevalence of Overweight Among US Adults
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,542
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Self-citationHyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Krotkiewski, M., Björntorp, P. A., Sjöström, L., & Smith, U. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111040 · Cited by 1,475
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
A Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,403
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Ohlson, L., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,143
Flagged first, then by citations
Research works printed but not linked: 1
- [15]15. L. DeGroot, editor. W.B. Saunders Company, Philadel- phia. 2624-2662.
Cited by
Sorted by citations
Items 801–895 of 895
Obesity and diabetes: never say never again!
Pietrobelli, A., Tosi, C., Kapantais, E., Rayner, G., & Kaklamanos, I. G. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01252.x
“Large adipocytes, such as those that are deposited in subcutaneous depots, are less sensitive to insulin than small adipocytes [12].”
BackgroundHoméostasie glucidique et insulinorésistance. Application aux situations de stress
Avignon, A., & Monnier, L. (1999) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(99)80003-x · Cited by 2
Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?
Wu, L. E., HOCKING, S. L., & James, D. E. (2010) · Diabetology International · doi:10.1007/s13340-010-0003-x
“For instance, while it is clear that obesity is associated with metabolic disease, there is a subset of individuals for whom obesity would appear not to be a risk at all [1].”
BackgroundFacteurs de risque de diabète de type 2 chez l’individu non obèse
Bonnet, F. (2013) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(13)70493-0
Diabetes mellitus und andere Störungen des Kohlenhydratstoffwechsels
Nauck, M. A. (2000) · Springer-Lehrbuch · doi:10.1007/978-3-642-57115-2_24
Pei, D., Lin, J., Wu, D.-A., Hsieh, C., Hung, Y.-J., Kuo, S., Kuo, K., Wu, C., & Li, J.-C. (2007) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2007.339
Hiperinsulinemia y cambios en el espesor intima media de la pared arterial
Vergara, M. A. (2007) · Americanae (AECID Library)
NOVEL GENES IN THE LIVER OF DIABETIC PSAMMOMYS OBESUS
Southon, A. G. (2002)
Geloneze, B., Pereira, J. A., Pareja, J. C., Carvalho, A., Lazarin, T., Chaves, I., de Souza, P., Tambascia, M. A., Chaim, É. A., & Muscelli, E. (2009)
The Effect of Hypothyroidism on Glucose Tolerance in Dogs
Hofer‐Inteeworn, N. (2008) · VTechWorks (Virginia Tech)
Hormonal regulation of phosphodiesterase 3B in adipocytes
Lindh, R. (2007) · Lund University Publications (Lund University)
Relación entre ácido úrico y estrés oxidativo en pacientes con síndrome metabólico
Martínez, A. M. G., & Benavides, C. A. P. (2008) · Repositorio Institucional (Pontificia Universidad Javeriana)
Metabolic phenotype in obese children and adolescents with preserved insulin sensitivity
Zdravković, D., Vuković, R., & Mitrović, K. (2012) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1246029z
“Nevertheless, it has been observed that not all obese children, as well as the obese adults, develop metabolic syndrome and other metabolic complications of the obesity, in other words a certain number of the obese have a normal metabolic phenotype (15, 16).”
BackgroundTyp-2-Diabetes mellitus und genetische Defekte der β-Zell-Funktion
Dugi, K. A., Kassessinoff, T. A., & Nawroth, P. (1999) · Springer eBooks · doi:10.1007/978-3-642-58588-3_4
Reply to M Manco et al and to MF McCarty
Chiu, K. C. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1452
Endocannabinoids and skeletal muscle glucose uptake.
Cavuoto, P. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Assessment and Treatment of Impaired Insulin- Secretion and Action in Type 2 Diabetes
Dorkhan, M. (2008) · Lund University Publications (Lund University)
Effect of High Cardiorespiratory Fitness and High Body Fat on Insulin Resistance
Shephard, R. J. (2007) · Yearbook of Sports Medicine · doi:10.1016/s0162-0908(08)70172-7
Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
Meiliana, A., & Wijaya, A. (2014) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v6i2.33 · Cited by 1
Reasner, C. A. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-17
Rhe´aume, P. P. A. C. (2008) · CRC Press eBooks · doi:10.3109/9781420060850-7
Nonsurgical Management of Obesity
Boan, J. (2005) · CRC Press eBooks · doi:10.1201/9781420038798.ch6
Metabolic Complications of Androgen Deprivation Therapy for the Treatment of Prostate Cancer
Taxel, H. A. P. (2015) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000205
“Although hypogonadism is not usually considered a risk factor for diabetes, it is recommended, based on recent data on ADT and insulin sensitivity [42-48] to treat all patients on ADT as high risk patients with close follow-up.”
BackgroundSolanki, J., Makwana, A., Mehta, H., Gokhale, P. A., & Shah, C. J. (2015) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.170906
Effects of high-fat feeding on skeletal muscle insulin signalling in sarcolipin knockout mice
Sayer, R. A. (2010) · UWSpace (University of Waterloo)
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Raja Babu, P., & Shakeela, D. (2016) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2016/556
Muhammad, H. F. L., & Huriyati, E. (2018) · Paediatrica Indonesiana · doi:10.14238/pi57.5.2017.1516
Лабораторна діагностика окремих компонентів метаболічного синдрому
Kobyliak, N. M., & Kyriienko, D. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.1.65.2015.75903
Bermúdez, V., Rojas, J., Salazar, J. J., Martínez, M. S., Olivar, L. C., Calvo, M. C. C., Mindiola, A., Áñez, R., Wilches-Durán, S., Cerda, M., et al. (2018) · F1000Research · doi:10.12688/f1000research.13897.1
Fetuin-A: a novel marker for obesity and associated comorbidities
Robinson, K. N. (2017) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Evaluation and Treatment of Insulin Resistance and Hyperglycemic States
Hurley, D. L., & Zangeneh, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_13
Elisha, B., Chabot, K., Fellahi, S., Taleb, N., Disse, E., Karelis, A. D., Prud’homme, D., RABASA-LHORET, R. P. R., & Bastard, J. P. (2017)
Endocrine Dysfunction in the Aged Horse
Messer, N. T. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160163-4/50009-8
Бойцов, С. А., & Goloshchapov, A. V. (2003) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2003-9-2-47-51
Influencia de la terapia antidiabética en la respuesta al tratamiento de la disfunción eréctil
Gutiérrez, L. S. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.137163
The effects of short-term low-carbohydrate and ketogenic interventions on cardiometabolic health
Myette‐Côté, É. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0378478
“Obesity is generally accompanied by metabolic impairments including insulin resistance and hyperinsulinemia [286].”
BackgroundEfeitos da suplementação com creatina sobre o metabolismo glicêmico: uma revisão sistemática
Ota, G. E., de Morais, C. S., Martinez, P. F., & de Oliveira-Junior, S. A. (2019) · Arquivos de Ciências do Esporte · doi:10.17648/aces.v6n4.2295
Preuss, H. G., Mrvichin, N., Bagchi, D., & Kaats, G. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816918-6.00017-2
Environmental risk factors for the occurrence of multiple sclerosis
Biström, M. (2020) · DiVA at Umeå University (Umeå University)
Insulin resistance and associated factors in healthy volunteers in South-west Nigeria
Adejumo, E., Adejumo, O., & Ogundahunsi, O. (2020) · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria) · doi:10.30442/ahr.0602-03-76
Singh, N. R., & Sandhu, I. M. S. (2019) · AMEI's Current Trends in Diagnosis & Treatment · doi:10.5005/jp-journals-10055-0074
Wolmarans, D. W., Steyn, S. F., & Brand, L. (2020) · South African General Practitioner · doi:10.36303/sagp.2020.3.0024
Comment justifier la chirurgie bariatrique chez les patients obèses ?
Rives‐Lange, C., Carette, C., & Czernichow, S. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75879-9.00001-9
Arterial Stiffness: Comment on the Article by Pavloska et al
Barzilay, J. I., & Garvey, W. T. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.002
Polycystic Ovarian Syndrome and Diabetes Mellitus
Nasr, M. Y., Alhuqayl, T. A., Alshammari, H. A., Alkhudhayri, H., Alzin, M. B., & Sulimani, R. A. (2021) · Journal of Nature and Science of Medicine · doi:10.4103/jnsm.jnsm_140_20
Update: Das Metabolische Syndrom
Toplak, H. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_34
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., & Lam, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-1
Brado, M., Bierhaus, A., Clemens, A., Dugi, K. A., Haass, M., Hammes, H., Herbay, A. V., Hofmann, M. A., Isermann, B., Kassessinoff, T. A., et al. (2001) · Springer eBooks · doi:10.1007/978-3-642-56784-1_16
Consequences of the Metabolic Syndrome
(2007) · Springer eBooks · doi:10.1007/978-1-84628-911-8_5
Bermúdez, V., Rojas, J., Salazar, J. J., Martínez, M. S., Olivar, L. C., Calvo, M. C. C., Mindiola, A., Áñez, R., Wilches-Durán, S., Cerda, M., et al. (2019) · F1000Research · doi:10.12688/f1000research.13897.2
Obese Patient in Intensive Care Unit
Koutsoukou, A., Kyriakopoulou, M., Kotanidou, A. N., & Economidou, F. N. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7836-2_19
Nauck, M. A. (2003) · Springer eBooks · doi:10.1007/978-3-642-55896-2_47
Resistência insulínica em mulheres saudáveis em idade reprodutiva
Melhado‐Kimura, V. (2014) · doi:10.47749/t/unicamp.2014.922332
Bermúdez, V., Rojas, J., Salazar, J. J., Martínez, M. S., Olivar, L. C., Calvo, M. C. C., Mindiola, A., Áñez, R., Wilches-Durán, S., Cerda, M., et al. (2021) · F1000Research · doi:10.12688/f1000research.13897.3
La intensidad de la actividad física y su papel en la prevención cardiovascular en la cohorte SUN
Hidalgo-Santamaría, M. (. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/63776
Ahlawat, A., Walia, V., & Garg, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1775288/v1
Reasner, C. A. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.011
The Impact Of Dietary Advanced Glycation Endproducts
Linkens, A. M. A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20221005al
Januszewski, A. S., & Jenkins, A. J. (2023) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_18-2
Hyperinsulenemia, Obesity, and T2 Diabetes: A continuum
Chawla, R. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01193-5
Cardiovascular Consequences of Metabolic Disturbances in Women
Turan, B. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_26
Central Control of Glucose Homeostasis
Alonge, K. M., Francis, K. L., Richardson, N. E., & Schwartz, M. W. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch10
A.Ali, H., Hussain, M. K., & Yasser, O. M. (2015) · Al-Kufa University Journal for Biology · doi:10.36320/ajb/v7.i3.8072
“Testosterone has been found to be the strongest independent factor explaining the high sympathetic nerve activity seen in women with PCOS (42) .”
BackgroundLee, J., Lim, S., & Lee, Y.-M. (2023) · Korean Journal of Human Ecology · doi:10.5934/kjhe.2023.32.6.845
İnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Effect of diabetes mellitus on treatment response in locally advanced carcinoma cervix patients
Shah, A., Kumar, D., Meedimale, S., Kaur, H., & Shukla, P. (2023) · Bengal Journal of Cancer · doi:10.4103/bjoc.bjoc_1_24
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407625.ch04
Kuzmina, I. Y., & Kuzmina, O. (2024) · Karazin Journal of Immunology · doi:10.26565/3083-5615-2024-13-05
Addressing a Key Metabolic Component of PCOS: Insulin
Hopkins, D., & Chappell, A. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1010981
Therapy of type 2 diabetes mellitus in comorbid patients: The place of sitagliptin
Dolgikh, Y. A., Bulgakova, S. V., Sharonova, L. A., Косарева, О. В., Treneva, E. V., Merzlova, P. Y., & Kurmaev, D. P. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-295
Vitamin D and metabolic syndrome-associated diseases: interconnections and implications
Ahmed, S., & Fatima, S. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34037-6.00009-1 · Cited by 1
Chhabria, S. M., Perez, J. A., & Neeland, I. J. (2025) · Obesity Science & Practice · doi:10.1002/osp4.70099
Assoumou, N., & Assoumou, H.-G. N. (2010)
Riccio, A., Fortin, E., Mellbin, L., Norhammar, A., Näsman, P., Rydén, L., Sesti, G., & Ferrannini, G. (2024) · Figshare · doi:10.6084/m9.figshare.24995588
Riccio, A., Fortin, E., Mellbin, L., Norhammar, A., Näsman, P., Rydén, L., Sesti, G., & Ferrannini, G. (2024) · Figshare · doi:10.6084/m9.figshare.24995475
Obésité et insulinorésistance : quels déterminants ? : inflammation, masse grasse ou triglycérides ?
Boursier, G. (2017) · theses.fr (ABES) · doi:10.70675/82f62752zb2c1z4f8fz82e0z694691e674b8
Le rôle du récepteur aux LDL et de PCSK9 dans le diabète de type 2
Ramin‐Mangata, S. (2020) · theses.fr (ABES) · doi:10.70675/26622ba5zb0fcz4d30za6e6z5c95a0b5a33d
Akar, E. A. (2022) · theses.fr (ABES) · doi:10.70675/a7b15e3fz84e7z4915z9447zc112181e06e4
Targeting hypothalamic SIK3 to promote weight loss and improve glycemic control in mice
Onda, D. A., Yang, C.-H., Goldsmith, C. C., Beddows, C. A., Teo, R. Q., Zhang, L., Yuan, X., Zhu, Y., Lee, M. H., Ovens, A. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73649-1
“Centralleptinandinsulinresistancearehallmarksofobesity 74,98,99 .”
Yılmaz, K. İ. A., Yılmaz, E., & Çamcı, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135273
“Due to these lipid imbalances, individuals with MetS exhibit a prothrombotic and proinflammatory state [13,44,45].”
Liu, X., Chen, Y., Yang, C., Li, J., Yao, Z., Zhang, Y., & Zhao, Y. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261472336
Biletska, O. M., Garyachiy, Y. V., & Shevchenko, A. S. (2026) · Experimental and Clinical Medicine · doi:10.35339/ekm.2026.95.2.bgs
Adiponectin : a novel circulating anti-thrombotic factor in humans?
Yousaf, T. A. (2011) · Repository@Hull (Worktribe) (University of Hull)
Casale, C. (2015) · UCL Discovery (University College London)
Metadata
- Authors
- Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G.
- Affiliations
- Istituto di Fisiologia Clinica (IT)
- Venue
- Journal of Clinical Investigation
- Published
- 1997-09-01
- Volume
- 100
- Issue
- 5
- Pages
- 1166-1173
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508292
- OpenAlex
- W2036400933
- Cited by
- 898
- References
- 53
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 20 · 2023: 13 · 2022: 20 · 2021: 28 · 2020: 32 · 2019: 26 · 2018: 32 · 2017: 26 · 2016: 26 · 2015: 36 · 2014: 30 · 2013: 36 · 2012: 43
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- Università degli Studi di Napoli Federico II
- Helsingin Yliopisto
- Universität Heidelberg
- Lunds Universitet
- Università degli Studi di Padova
- National and Kapodistrian University of Athens
- Université de Genève
- Università degli Studi di Torino
- Università degli Studi di Verona
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, insulin hypersecretion, obesity, insulin sensitivity, body mass index, waist circumference, waist-to-hip ratio, abdominal obesity, sex differences, hyperinsulinemic-euglycemic clamp, type 2 diabetes risk
- MeSH terms
- Insulin Secretion, Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
